METHOD FOR ASSESSING ALCOHOLIC ANOSOGNOSIA AND DIFFERENTIATED APPROACHES TO PSYCHOTHERAPEUTIC AND MEDIATED PSYCHOPHARMACOLOGICAL CORRECTION OF ALCOHOLIC ANOSOGNOSIA IN ALCOHOL ADDICTED PATIENTS Russian patent published in 2014 - IPC A61B5/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely addictology, and may be used for treating anosognosia in alcohol addicted patients. The alcohol addicted patients are presented with a questionnaire to be filled in and further processed; the derived data 'Alcoholic Anosognosia' are analysed by seven sub-scales: 'uninformedness', 'non-recognition of the symptoms', 'non-recognition of the disease', 'non-recognition of the consequences', 'emotional rejection of the disease', 'disagreement with the treatment', 'rejection of abstinence'; sub-scale 'uninformedness', 'non-recognition of the symptoms', 'non-recognition of the disease as a whole', 'non-recognition of the consequences' are cognitive sub-scales; 'emotional rejection of the disease' is an emotional sub-scale, 'disagreement with the treatment' and 'rejection of abstinence' are motivational sub-scales. Anosognosia levels are assessed. Diagnostically valuable manifestations levels - medium, increased and high - are recorded. The sub-scale 'uninformedness' is used for psychoeducation trainings for the patients and their families. The sub-scale non-recognition of the symptoms' provides a basis for rational psychotherapy that aims at the expression of core symptoms of alcohol addiction in a specific patient. According to the sub-scale 'non-recognition of the disease', the rational psychotherapy lays an emphasis on the presence of alcohol addiction and accents its chronic clinical course. The sub-scale 'non-recognition of the consequences' is used to perform the rational psychotherapy that involves a discussion on the effect of alcohol addiction in the specific patient on the family, occupation, and on the psychic and somatic health. According to the sub-scale 'emotional rejection of the disease', the psychotherapeutic treatment is ensured through actualisation of patient's spontaneous disease-related experience with using various types of emotionally oriented psychotherapy. The sub-scale 'disagreement with the treatment' suggests a motivational intervention that is a motivational interview. The sub-scale 'rejection of abstinence' requires a cognitive-behavioural therapy aiming at the formation of alcohol refusal motivation, development and fixation of an abstinent behaviour. The cognitive sub-scales provide the mediated psychopharmacological correction of alcoholic anosognosia by using nootropic agents. The mediated psychopharmacological correction of alcoholic anosognosia as per the sub-scale 'emotional rejection of the disease' by using the drug preparations possessing mood stabilising agents.

EFFECT: method enables providing higher accuracy of assessing anosognosia in the alcohol addicted patients, as well as higher clinical effectiveness in alcohol addiction.

18 tbl, 3 ex